ARTICLE | Financial News
TiGenix amends follow-on
October 31, 2016 7:00 AM UTC
TiGenix N.V. (Euronext:TIG), Leuven, BelgiumBusiness: Gene/Cell therapy, Autoimmune, MusculoskeletalDate announced: 2016-10-26Type: Follow-onTo be raised: TBDShares: TBDPrice Prior: EUR0.99Underwriter...